WHEAT RIDGE, CO / ACCESS Newswire / March 27, 2026 / Lifeloc Technologies, Inc. (OTC:LCTC), a global leader in the ...
Reported positive preclinical results for lead drug candidate EB-003, showing statistically significant improvements in animal models of severe chronic depression and despair and in post-traumatic ...
Market OverviewThe global MedTech Contract Manufacturing Organization (CMO) market is witnessing robust growth, expanding at ...
Electronic Caregiver is proud to sponsor the Always Best Care Conference LAS CRUCES, NM / ACCESS Newswire / March 27, 2026 / ...
For global buyers, the evolution of Chinese innovative drugs is no longer merely about “more choices” — it has become a ...
Presentation will Cover Recent Corporate Milestones Including Securing Agreement with NIAID SAN ANTONIO, TX / ACCESS Newswire ...
NDA submission for Emcitate® successfully validated by the FDAPriority Review granted and PDUFA target action date set to ...
Demands Openness to Evaluating Credible Opportunities to Maximize Shareholder ValueUnderscores the Company’s Sustained Value Destruction, Lack of Permanent Leadership, and Board’s Poor Alignment with ...
MALMÖ, SE / ACCESS Newswire / March 27, 2026 / Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people ...
Popular event series anchors growing slate of accessible continuing education solutions IRVINE, CA / ACCESS Newswire / March ...
Company accelerated development of the enVVe® System, completing pre-clinical studies and progressing toward a 2026 pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results